• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

    6.740 -0.150 (-2.18%)
    Streaming Delayed Price Updated: 11:12 AM EDT, Aug 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about SciSparc Ltd. - Ordinary Shares

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
    From SciSparc Ltd
    Via GlobeNewswire
    Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗
    Via Chartmill
    Top movers analysis one hour before the close of the markets on 2026-07-29: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's regular session. The market value of their outstanding shares is at $1.4 million. SciSparc (NASDAQ:SPRC)... 
    Via Benzinga
    These stocks are moving in today's session ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Wednesday's session. ↗
    Via Chartmill
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
    From SciSparc Ltd
    Via GlobeNewswire
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    Which stocks are gapping on Thursday? ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Thursday. ↗
    Via Chartmill
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Neurothera Labs Inc. Announces Closing Of Acquisition Of Majority Stake In Cliniquantum Ltd.
    Toronto, Ontario – June 3, 2026 – TheNewswire – NeuroThera Labs Inc. (TSXV: NTLX) (the “Company” or “NeuroThera”), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd.... 
    Via TheNewswire.com
    Topics Intellectual Property
    Top movers in Friday's pre-market session ↗
    Via Chartmill
    News headline image
    Why Is SciSparc Stock Skyrocketing On Thursday? ↗
    Discover why SciSparc Ltd. (NASDAQ: SPRC) stock is surging today after subsidiary NeuroThera Labs receives TSX approval for a key majority stake acquisition. 
    Via Benzinga
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
    From SciSparc Ltd
    Via GlobeNewswire
    These stocks are moving in today's session ↗
    Via Chartmill
    Unusual volume stocks are being observed in Tuesday's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Tuesday's session. ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
    From SciSparc Ltd
    Via GlobeNewswire
    Which stocks are moving on Tuesday? ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.